Literature DB >> 18362879

A potentially aborted neuroleptic malignant syndrome following seclusion against uncontrollable water intoxication.

Takefumi Suzuki1, Hiroyuki Uchida, Koichiro Watanabe, Haruo Kashima.   

Abstract

Water intoxication in schizophrenia poses a great clinical challenge, and occasionally, behavioral restrictions are unavoidable. A patient with refractory schizophrenia comorbid with severe water intoxication had an apparent weight variation of ,7 kg/day to 65 kg. As he fell twice, when he had been treated with antipsychotic megadose therapy, he was secluded with restricted water access of 3 L/day. Two days later, consciousness level deteriorated significantly with autonomic instability; however, he was treated with intravenous hydration plus dantrolene and recovered completely on the following day. The sodium/chloride levels and serum osmolarity, which had been abnormally low, normalized abruptly. Only after seclusion was it found that his dry weight had been only 52 kg. The first description of such a case was indicative of a potentially aborted neuroleptic malignant syndrome. He is now treated with olanzapine, valproate, and lorazepam, with some success. Caution is required for secluding extreme cases of uncontrollable water intoxication.

Entities:  

Mesh:

Year:  2008        PMID: 18362879

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  2 in total

Review 1.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

2.  Case Report: A Patient With Neuroleptic Malignant Syndrome, Water Intoxication and Hyponatremia Associated With Severe Cerebral Edema and Coma.

Authors:  Haruka Takenouchi; Takatoshi Anno; Yukiko Kimura; Fumiko Kawasaki; Ryo Shirai; Hideaki Kaneto; Katsumi Kurokawa; Koichi Tomoda
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-10       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.